Modulation of tumor oxygenation.
There is a large body of evidence suggesting that deficiencies in the O2 supply of tumors exist due to restrictions (i) in the O2 delivery by perfusion and/or diffusion, and (ii) in the O2 transport capacity. Whereas the former are mostly based on inadequate and heterogeneous microcirculatory functions, the latter are predominantly due to tumor-associated anemia. Possible uses and limitations of measures are discussed which can increase the microvascular O2 content and thus may preferentially serve to enhance diffusion-limited O2 availability. In addition, means are described for improving and increasing the uniformity of microcirculation thus possibly enhancing perfusion-limited O2 delivery. Reducing cellular respiration rate should be of benefit in both pathophysiological conditions. Because both types of O2 limitation coexist in solid tumors, appropriate combinations should be aimed at eradicating tumor hypoxia which is present in at least one third of cancers in the clinical setting.
Vaupel
P
P
Institute of Physiology and Pathophysiology, University of Mainz, Germany.
Kelleher
D K
DK
Thews
O
O
D000740:Anemia / Q000628:therapy; D000818:Animals; D002263:Carboxyhemoglobin / Q000378:metabolism; D015687:Cell Hypoxia / Q000502:physiology; D017707:Erythrocyte Transfusion; D005544:Forecasting; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D006931:Hyperbaric Oxygenation; D008833:Microcirculation; D009369:Neoplasms / Q000098:blood supply* / Q000378:metabolism* / Q000628:therapy; D010100:Oxygen / Q000008:administration & dosage / Q000097:blood; D010101:Oxygen Consumption / Q000502:physiology*; D010313:Partial Pressure
D006454:Hemoglobins; D002263:Carboxyhemoglobin; D010100:Oxygen